INTEGER CLASS ACTION: Integer Holdings (ITGR) Accused of Misrepresentations About Its Sales Outlook in Securities Lawsuit, Contact BFA Law by February 9 Ready to Announce with Confidence?
New York, New York--(Newsfile Corp. - February 6, 2026) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws.
If you invested in Integer, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit.
Investors have until February 9, 2026, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Integer common stock. The case is pending in the U.S. District Court for the Southern District of New York and is captioned West Palm Beach Firefighters' Pension Fund v. Integer Holdings Corporation, et al., No. 1:25-cv-10251.
Why is Integer Being Sued for Securities Fraud?
Integer designs and manufactures cardiac rhythm management and cardiovascular products, including electrophysiology ("EP") devices that map the heart's electrical activity to diagnose and treat arrhythmias.
During the relevant period, Integer repeatedly touted its EP sales growth and market position while overstating demand for its EP devices.
As alleged, in truth, demand for and revenue from Integer's EP products had fallen sharply-directly contradicting the Company's public assurances.
Why did Integer's Stock Drop?
On October 23, 2025, Integer disclosed that it lowered its 2025 sales guidance to a range between $1.840 billion and $1.854 billion, from a range between $1.850 billion and $1.876 billion, and well below analysts' estimates. The Company also revealed that it expected poor net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026. Integer also admitted that two of its EP devices experienced "slower than forecasted" adoption and that it expected the slower demand "to continue into 2026." This news caused the price of Integer stock to drop $35.22 per share, or more than 32%, from a closing price of $109.11 per share on October 22, 2025, to $73.89 per share on October 23, 2025.
Click here for more information: https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit.
What Can You Do?
If you invested in Integer, you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
Submit your information by visiting:
https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit
Or contact:
Adam McCall
adam@bfalaw.com
212.789.3619
Why Bleichmar Fonti & Auld LLP?
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit
Attorney advertising. Past results do not guarantee future outcomes.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282901
Source: Bleichmar Fonti & Auld
Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Bleichmar Fonti & Auld or all companies in the Banking / Financial Services, Investment Banking industry.
ARDENT HEALTH CLASS ACTION: Ardent Health, Inc. (ARDT) Accused of Misrepresentations About Its Revenue in Securities Lawsuit, Contact BFA Law by March 9
2026-02-06 6:36 AM EST
BELLRING CLASS ACTION: BellRing Brands, Inc. (BRBR) Accused of Misrepresentations About Its Elevated Inventory in Securities Fraud Lawsuit, Contact BFA Law by March 23
2026-02-06 6:36 AM EST
COREWEAVE CLASS ACTION: CoreWeave, Inc. (CRWV) Accused of Misrepresentations About Its Infrastructure Delays in Securities Fraud Lawsuit, Contact BFA Law by March 13
2026-02-06 6:36 AM EST
Dec 18, 2025
In 2025, more than 39,000 press releases distributed through Newsfile offer a clear lens into how public companies are communicating with the market. At this scale, individual announcements fade into the background, and what emerges instead are patterns . The language companies choose reveals how industries are evolving, where credibility is being built, and what investors are being asked to trust. Last year, this analysis focused on identifying the most common keywords by industry. This...
Litigation and Regulation
Banking / Financial Services
Investment Banking